What Revvity, Inc. told the SEC could break it.

For certain critical raw materials, key components and supplies used in some principal products, Revvity has qualified only a limited or single source of supply; a disruption from these limited/single-source suppliers could adversely affect operations and customer relationships, mitigated by excess advance purchases and (with sufficient lead time) alternative qualification.

“For certain critical raw materials, key components and supplies required for the production of some of our principal products, we have qualified only a limited or a single source of supply.”

Increased tariffs (and unfavorable FX and product-mix shift, including from China diagnostic-testing policy changes) compressed Revvity's gross and segment operating margins in fiscal 2025 — diagnostics segment operating margin fell ~194bps; trade barriers/retaliatory measures could further disrupt its supply chain and customers.

“Segment operating margin decreased 194 basis points to 24.2% in fiscal year 2025, as compared to 26.1% in fiscal year 2024, primarily due to increased tariffs, unfavorable changes in foreign exchange rates, and product mix shift due to China diagnostic testing policy changes.”

Approximately 60% of Revvity's business is conducted outside the US, generally in foreign currencies, so exchange-rate fluctuations can increase financing/investing/operating costs; it uses forward contracts to mitigate transaction exposures but not for speculation.

“Approximately 60 % of the Company's business is conducted outside of the United States, generally in foreign currencies. As a result, fluctuations in foreign currency exchange rates can increase the costs of financing, investing and operating the business.”